Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease

Finehout, Erin J., Franck, Zsofia, Choe, Leila H., Relkin, Norman, Lee, Kelvin H.·2007·Annals of Neurology

Abstract

Objective: To find a panel of proteins in antemortem cerebrospinal fluid (CSF) that could be used to differentiate between samples from Alzheimer's disease (AD) patients and samples from healthy and neurological control subjects. Methods: For a test cohort, antemortem CSF proteins from 34 AD and 34 non‐AD patients were separated using two‐dimensional gel electrophoresis. The resulting protein patterns were analyzed using the random forest multivariate statistical method. Protein spots of interest were identified using tandem time‐of‐flight mass spectrometry. A validation cohort consisting of CSF from 18 AD patients and 10 non‐AD subjects was analyzed in a similar way. Results: Using the test cohort, a panel of 23 spots was identified that could be used to differentiate AD and non‐AD gels with a sensitivity of 94%, a specificity of 94%, and a predicted classification error rate of only 5.9%. These proteins are related to the transport of β‐amyloid, the inflammatory response, proteolytic inhibition, and neuronal membrane proteins. The 23 spots separately classified the validation cohort with 90% sensitivity (probable AD subjects), 83% specificity, and a predicted classification error rate of 14% in a blinded analysis. The total observed sensitivity is 93%, the total observed specificity is 90%, and the predicted classification error rate is 8.3%. Interpretation: A panel of possible CSF biomarkers for AD has been identified using proteomic methods. Ann Neurol 2006

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21038

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 184

Metadata

Authors
Finehout, E. J., Franck, Z., Choe, L. H., Relkin, N., & Lee, K. H.
Venue
Annals of Neurology
Publisher
Wiley
Published
2006-12-13
Volume
61
Issue
2
Pages
120-129
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2041032262
Cited by
184
References
4
FWCI
10.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.21038
The paper
Finehout, E. J., Franck, Z., Choe, L. H., Relkin, N., & Lee, K. H. (2007). Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.21038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.